Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Teriparatide

EU orphan designation number: EU/3/16/1689   
Active ingredient: Teriparatide
Indication: Treatment of hypoparathyroidism
Sponsor: Alacrita LLP
London BioScience Innovation Centre, 2 Royal College Street,London NW1 0NH,United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/06/2016 Orphan designation EMA/OD/031/16 (2016)4130 of 27/06/2016